| Stocks Slip as Market Balks at 1,700 Major U.S. stock markets are dipping in the red Thursday even after Facebook exceeds earnings estimates amid signs of a strengthening U.S. recovery. 7/25/2013 9:22 AM EDT Next Big Samsung Phone May Have Screen Problems Samsung is said to be facing problems fitting an even larger screen into the upcoming Galaxy Note III 7/25/2013 9:50 AM EDT Facebook Flexes Mobile Muscle (Update 1) Facebook's second-quarter earnings showcase the company's mobile strength -- a trend that's poised to continue. 7/25/2013 8:27 AM EDT SiriusXM Drives Toward $4 a Share SiriusXM beats earnings estimates on low churn and high conversion rate, as shares continue to outperform 7/25/2013 9:25 AM EDT Travel Site TripAdvisor Hits All-Time High as Advertising Surges The online travel research site took off on Thursday after 2Q13 earnings report showed booming advertisements. 7/25/2013 11:40 AM EDT Global Macro: Oh, Bearish Canada Canadian equties are bound to break lower on lower commodities and higher Treasury rates. 7/25/2013 7:36 AM EDT Money May Be Talking When Your Doc Recommends a Specialist Why marketing, more than reputation, may have the influence. 7/25/2013 10:54 AM EDT Blue-collar Americans Are Getting Stiffed on Auto Insurance Rates The less education you have, the more you pay. 7/25/2013 11:15 AM EDT Should Retirees Rely on Target-Date Funds? Funds with big stock allocations are likely to succeed. 7/25/2013 9:59 AM EDT New China ETF Targets Nation's Five-Year Plan This China-focused exchange-traded fund avoids financials but is very heavy in technology. 7/25/2013 9:38 AM EDT What This Red-Hot Stock Has to Do With Angelina Jolie Illumnia has developed an integrated system to analyze genetic variations. 7/24/2013 5:39 PM EDT GM's Earnings Hit the Gas Pedal General Motors reported better-than-expected second-quarter earnings, boosted by demand for pick-up trucks in North America and cost-cutting in Europe. 7/25/2013 9:55 AM EDT Cramer: Qualcomm Can Add $11 Jim Cramer believes Qualcomm can go even higher and Citigroup's negative opinion is wrong. 7/25/2013 11:05 AM EDT Biotech's Next Big Thing: Aegerion Aegerion and its cholesterol drug will be biotech's big thing in the coming week, says Adam Feuerstein, Sr. columnist for TheStreet. 7/25/2013 11:04 AM EDT
Sponsored Links 
| 
No comments:
Post a Comment